Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
09/2003
09/17/2003EP1343870A2 Bacterial expression systems
09/17/2003EP1343869A2 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
09/17/2003EP1343819A1 Hla-a2.1 binding peptides and their uses
09/17/2003EP1343807A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
09/17/2003EP1343371A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
09/17/2003EP1266035A4 Improved methods for generating catalytic proteins
09/17/2003EP1230260B1 Hcv ns3 protease inhibitors
09/17/2003EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis
09/17/2003EP1124941B1 Process for recovering heterologous polypeptides from bacterial cells
09/17/2003EP1019482A4 Soaps produced from high laurate canola oil-based fatty acids
09/17/2003EP0981627B1 Purified telomerase
09/17/2003EP0840784B1 Method of producing and purifying enzymes
09/17/2003CN1443240A Interferon-like protein zcyto 21
09/17/2003CN1443237A Cell-wall degrading enzyme variants
09/17/2003CN1443236A Novel amylolytic enzyme extracted from bacillus SP.A7-7(DSM 12368)and washing and cleaning agents containing this novel amylolytic enzyme
09/17/2003CN1443234A Direct enzyme agglomeration process
09/17/2003CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/17/2003CN1443058A Enzyme composition for bleaching human keratinous fibres and bleaching method
09/17/2003CN1443038A Model for neurodegenerative disease
09/17/2003CN1442202A Biological preparation for preventing and treating heart and brain blood vessel disease and its application
09/17/2003CN1121500C Method for production of dicarboxylic acids
09/17/2003CN1121499C Process for producing moroctic acid by induction
09/17/2003CN1121497C D-pantolactone hydrolase and gene encoding the same
09/16/2003US6620987 Nucleic acid encoding a starch R1 phosphorylation protein homolog from maize
09/16/2003US6620985 Given nucleotide sequence; use for enhancing disease resistance of plants
09/16/2003US6620924 Thermostable glucoamylase
09/16/2003US6620922 Isolated polynucleotide of given sequence; kit
09/16/2003US6620844 Treating obesity and non-insulin-dependent (type II) diabetes mellitus (NIDDM) by specifically targeting the genes and gene products of cathepsins
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/16/2003US6620616 Nucleic acids encoding nitric oxide synthase variants
09/16/2003US6620611 Solid-chemical composition for sustained release of organic substrates and complex inorganic phosphates for bioremediation
09/16/2003US6620608 Peptides for use in the treatment of cholesterol defects
09/16/2003US6620607 Polypeptides having amino acid sequences coded by genes within the human genome, used as proteolytic enzymes for therapy and medical diagnosis
09/16/2003US6620606 New human cathepsin (LCAP) and polynucleotides which identify and encode LCAP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders
09/16/2003US6620605 Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
09/16/2003US6620604 Plant extracts comprising polypeptides which desulfate galactans present in hydrocolloids; sulfatase; hydrolase enzymes
09/16/2003US6620603 Human mitogenic oxidase
09/16/2003US6620601 Genetic ligation of operons containing promoters and genes, to vectors, then inserting into plastid chromosomes; agricultural cultivation
09/16/2003US6620593 Drug screening using oxidoreductase enzymes, then analyzing the metabolites for toxicity, mutagenicity or carcinogenicity
09/16/2003US6620592 Nucleotide sequences coding enzymatic polypeptides; for use in treatment of defects in cell proliferation and immunological response; for use prevention and treatment of stroke and alzheimer's disease; antiischemic agents
09/16/2003US6620351 Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
09/16/2003CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors
09/16/2003CA2087724C Reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases
09/16/2003CA2015046C Recombinant dna and expression vector
09/12/2003WO2003074728A2 Screening for modulators of pkng activity
09/12/2003WO2003074716A2 Methods for the production of unsaturated fatty acids
09/12/2003WO2003074715A2 Process for the production of unsaturated fatty acids
09/12/2003WO2003074710A1 Polynucleotides, polypeptides and process for producing polypeptide
09/12/2003WO2003074709A1 Yam-origin chitinase of family 19 and class iv
09/12/2003WO2003074708A1 Sulfotransferase, its polypeptide and dna encoding the same
09/12/2003WO2003074707A1 Dna and vector for regulating the expression of lachrymator synthase gene, method of regulating the expression of lachrymator synthase gene using the same, and plant with the regulated expression of lachrymator synthase gene
09/12/2003WO2003074706A1 PROTEIN OR POLYPEPTIDE HAVING LACHRYMATOR SYNTHASE ACTIVITY, DNA ENCODING THE PROTEIN OR THE POLYPEPTIDE, PROCESS FOR PRODUCING PROTEIN OR POLYPEPTIDE HAVING LACHRYMATOR SYNTHASE ACTIVITY USING THE DNA, AND NUCLEIC ACID MOLECULE INHIBITING THE TRANSLATION OF mRNA CONCERNING THE PROTEIN OR THE PEPTIDE
09/12/2003WO2003074697A1 Method of modifying protein properties
09/12/2003WO2003074690A1 Amino acid racemase having low substrate specificity and process for producing racemic amino acid
09/12/2003WO2003074689A1 Treatment of staphylococcus infections using transgenic expression of a modified lysostaphin gene
09/12/2003WO2003074688A2 Polynucleotides encoding a beta-glucosidase and uses thereof
09/12/2003WO2003074687A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003WO2003074677A2 MCHKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE
09/12/2003WO2003074676A2 Wax ester synthase dna sequence, protein and uses thereof
09/12/2003WO2003074673A2 Lgals as modifiers of the chk pathway and methods of use
09/12/2003WO2003074670A2 Lis promoter for expression of transgenes in floral tissues
09/12/2003WO2003074669A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
09/12/2003WO2003074667A2 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells
09/12/2003WO2003074666A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
09/12/2003WO2003074660A2 Modified chitin binding domain and uses thereof
09/12/2003WO2003074543A1 Anti-protozoal vaccine
09/12/2003WO2003074089A1 Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof
09/12/2003WO2003074087A1 Coupling proteins to a modified polysaccharide
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074068A2 Use of soluble fgl2 as an immunosuppressant
09/12/2003WO2003074004A2 Method of producing antigens
09/12/2003WO2003073980A2 Recombinant protein c variants
09/12/2003WO2003073839A2 Expression of lysosomal enzymes in plant seeds
09/12/2003WO2003066844A3 Cytochrome p450 protein
09/12/2003WO2003051916A3 Crystal structure of nh3-dependent dad+ synthetase from streptococcus pneumoniae
09/12/2003WO2003035884A3 Transient immortalization
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003031579A3 Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor
09/12/2003WO2003029452A3 Method for the production of oily suspensions of water-soluble enzymes
09/12/2003WO2003012091A3 Fatty acid desaturase gene obtained from pomegranate and method for the production of unsaturated fatty acids
09/12/2003WO2003007794A3 Invasion complex and methods of targeting
09/12/2003WO2002079224A3 Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
09/12/2003WO2002074960A3 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
09/12/2003WO2002070677A3 Palmityl transferases
09/12/2003WO2002059284A3 33217, a human amp-binding enzyme family member and uses thereof
09/12/2003WO2002040658A3 Isomerases
09/12/2003WO2002033059A9 Gnk interacting amino acid decarboxylase and methods of use thereof
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002010454A3 Haplotypes of the alas2 gene
09/12/2003WO2002010401A9 18431 and 32374, human protein kinase family members and uses therefor
09/12/2003WO2002010355A3 Alpha-amylase mutants with altered stability
09/12/2003WO2001083800A9 Heterologous production of polyketides
09/12/2003CA2818688A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2478391A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
09/12/2003CA2478024A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
09/12/2003CA2478015A1 Dna and vector for regulating the expression of lachrymator synthase gene, method of regulating the expression of lachrymator synthase gene using the same, and plant with the regulated expression of lachrymator synthase gene
09/12/2003CA2478014A1 Protein or polypeptide having lachrymator synthase activity, dna encoding the protein or the polypeptide, process for producing protein or polypeptide having lachrymator synthase activity using the dna, and nucleic acid molecule inhibiting the translation of mrna concerning the protein or the peptide
09/12/2003CA2477876A1 Recombinant protein c variants
09/12/2003CA2477858A1 Process for the production of unsaturated fatty acids
09/12/2003CA2477794A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host